Organogenesis Holdings (ORGO) Stock Statistics & Valuation Metrics

Organogenesis Holdings has a market cap or net worth of $105.55M. The enterprise value is $362.75M.

Market Cap

$105.55M

Enterprise Value

$362.75M

Organogenesis Holdings has 129,801,730 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

129,801,730

Owned by Insiders

16.85%

Owned by Institutions

21.18%

Organogenesis Holdings’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 8.52%.

Return on Equity (ROE)

0.09

Return on Assets (ROA)

0.06

Return on Invested Capital (ROIC)

8.52%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

659.29K

Profits Per Employee

43.36K

Employee Count

854

Asset Turnover

0.94

Inventory Turnover

4.64

The current PE Ratio of Organogenesis Holdings is -0.77. Organogenesis Holdings’s PEG ratio is -0.00.

PE Ratio

-0.77

PS Ratio

0.33

PB Ratio

0.98

Price to FCF

-1823.76

Price to Operating Cash Flow

11.36

PEG Ratio

-0.00

In the last 12 months, Organogenesis Holdings had revenue of 563.03M and earned 37.03M in profits. Earnings per share was 0.16.

Revenue

563.03M

Gross Profit

425.51M

Operating Income

55.87M

Pretax Income

46.97M

Net Income

37.03M

EBITDA

73.91M

Earnings Per Share (EPS)

0.16

In the last 12 months, operating cash flow was 10.30M and capital expenditures -10.36M, giving a free cash flow of -64.00K billion.

Operating Cash Flow

10.30M

Free Cash Flow

-64.00K

Free Cash Flow per Share

-0.00

Organogenesis Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-0.05%

Earnings Yield

-123.57%

Beta

1.37

52-Week Price Change

-79.10%

50-Day Moving Average

1.26

200-Day Moving Average

2.27

Relative Strength Index (RSI)

28.22

Average Volume (3m)

811.28K

Organogenesis Holdings upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 05, 2026

Next Earnings Date

Mar 04, 2027

Ex-Dividend Date

―

Organogenesis Holdings as a current ratio of 3.62, with Debt / Equity ratio of 30.62%

Current Ratio

3.62

Quick Ratio

3.32

Debt to Market Cap

0.11

Net Debt to EBITDA

0.53

Interest Coverage Ratio

0.00

In the past 12 months, Organogenesis Holdings has paid 9.94M in taxes.

Income Tax

9.94M

Effective Tax Rate

0.21

Organogenesis Holdings EV to EBITDA ratio is -2.69, with an EV/FCF ratio of -2498.40.

EV to Sales

0.45

EV to EBITDA

-2.69

EV to Free Cash Flow

-2498.40

EV to Operating Cash Flow

15.52

Organogenesis Holdings has $21.33M in cash and marketable securities with $64.52M in debt, giving a net cash position of -$43.19M billion.

Cash & Marketable Securities

$21.33M

Total Debt

$64.52M

Net Cash

-$43.19M

Net Cash Per Share

-$0.33

Tangible Book Value Per Share

$1.79

Gross margin is 55.28%, with operating margin of -22.84%, and net profit margin of -41.13%.

Gross Margin

55.28%

Operating Margin

-22.84%

Pretax Margin

-24.34%

Net Profit Margin

-41.13%

EBITDA Margin

-16.91%

EBIT Margin

-15.91%

The average price target for Organogenesis Holdings is $2.00, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target

$2.00

Price Target Upside

146.00% Upside

Analyst Consensus

Neutral

Analyst Count

2

Revenue Growth Forecast

-24.33%

EPS Growth Forecast

-1171.44%

Smart Score

4

AI Score

43